Malignant neoplasm of prostate C61-

by

Malignant neoplasm of prostate C61-

Use Additional

  • code, if applicable, to identify:
  • hormone sensitivity status (Z19.1-Z19.2)
  • rising PSA following treatment for malignant neoplasm of prostate (R97.21)

Type 1 Excludes

  • malignant neoplasm of seminal vesicle (C63.7)

Clinical Information

  • A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas.
  • The prostate is the gland below a man’s bladder that produces fluid for semen. Prostate cancer is common among older men. It is rare in men younger than 40. Risk factors for developing prostate cancer include being over 65 years of age, family history, being african-american, and some genetic changes.symptoms of prostate cancer may include
    • problems passing urine, such as pain, difficulty starting or stopping the stream, or dribbling
    • low back pain
    • pain with ejaculation
    your doctor will diagnose prostate cancer by feeling the prostate through the wall of the rectum or doing a blood test for prostate-specific antigen (psa). Other tests include ultrasound, x-rays, or a biopsy.treatment often depends on the stage of the cancer. How fast the cancer grows and how different it is from surrounding tissue helps determine the stage. Men with prostate cancer have many treatment options. The treatment that’s best for one man may not be best for another. The options include watchful waiting, surgery, radiation therapy, hormone therapy, and chemotherapy. You may have a combination of treatments. nih: national cancer institute

Codes

  •  C61 Malignant neoplasm of prostate